Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP)
Gespeichert in:
| Weitere Verfasser: | , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2013
|
| In: |
Annals of oncology
Year: 2013, Jahrgang: 24, Heft: 10, Pages: 2576-2581 |
| ISSN: | 1569-8041 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S0923753419370942
|
| Verfasserangaben: | Fensterer, H. ... Maerten, A.; Ebert, M. P. ... Hofheinz, R. ... |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1480508411 | ||
| 003 | DE-627 | ||
| 005 | 20241008131110.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 140807s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/annonc/mdt270 |2 doi | |
| 035 | |a (DE-627)1480508411 | ||
| 035 | |a (DE-576)410508411 | ||
| 035 | |a (DE-599)BSZ410508411 | ||
| 035 | |a (OCoLC)1340643558 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 245 | 0 | 0 | |a Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP) |c Fensterer, H. ... Maerten, A.; Ebert, M. P. ... Hofheinz, R. ... |
| 264 | 1 | |c 2013 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am: 07.08.2014 | ||
| 700 | 1 | |a Fensterer, Heiko |0 (DE-588)173360947 |0 (DE-627)69827718X |0 (DE-576)134208226 |4 oth | |
| 700 | 1 | |a Märten, Angela |d 1968- |0 (DE-588)122240103 |0 (DE-627)081822456 |0 (DE-576)293167931 |4 oth | |
| 700 | 1 | |a Ebert, Matthias |d 1968- |0 (DE-588)1030133522 |0 (DE-627)734827083 |0 (DE-576)377938432 |4 oth | |
| 700 | 1 | |a Hofheinz, Ralf-Dieter |d 1969- |0 (DE-588)121917517 |0 (DE-627)08161876X |0 (DE-576)292991568 |4 oth | |
| 773 | 0 | 8 | |i In |t Annals of oncology |d Amsterdam [u.a.] : Elsevier, 1990 |g 24(2013), 10, Seite 2576-2581 |h Online-Ressource |w (DE-627)320428796 |w (DE-600)2003498-2 |w (DE-576)098134345 |x 1569-8041 |7 nnas |a Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP) |
| 773 | 1 | 8 | |g volume:24 |g year:2013 |g number:10 |g pages:2576-2581 |g extent:6 |a Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP) |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S0923753419370942 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20140807 | ||
| 993 | |a Article | ||
| 994 | |a 2013 | ||
| 998 | |g 122240103 |a Märten, Angela |m 122240103:Märten, Angela |d 910000 |d 910200 |e 910000PM122240103 |e 910200PM122240103 |k 0/910000/ |k 1/910000/910200/ |p 9 | ||
| 998 | |g 121917517 |a Hofheinz, Ralf-Dieter |m 121917517:Hofheinz, Ralf-Dieter |d 60000 |d 61100 |e 60000PH121917517 |e 61100PH121917517 |k 0/60000/ |k 1/60000/61100/ |p 12 | ||
| 998 | |g 1030133522 |a Ebert, Matthias |m 1030133522:Ebert, Matthias |d 60000 |d 61100 |e 60000PE1030133522 |e 61100PE1030133522 |k 0/60000/ |k 1/60000/61100/ |p 10 | ||
| 999 | |a KXP-PPN1480508411 |e 2810826080 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"role":"oth","given":"Heiko","display":"Fensterer, Heiko","family":"Fensterer"},{"role":"oth","given":"Angela","display":"Märten, Angela","family":"Märten"},{"family":"Ebert","display":"Ebert, Matthias","role":"oth","given":"Matthias"},{"family":"Hofheinz","given":"Ralf-Dieter","role":"oth","display":"Hofheinz, Ralf-Dieter"}],"name":{"displayForm":["Fensterer, H. ... Maerten, A.; Ebert, M. P. ... Hofheinz, R. ..."]},"note":["Gesehen am: 07.08.2014"],"relHost":[{"note":["Gesehen am 12.11.20","Ungezählte Beil.: Supplement"],"corporate":[{"display":"European Society for Medical Oncology","role":"isb"}],"disp":"Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP)Annals of oncology","physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2003498-2"],"issn":["1569-8041"],"eki":["320428796"]},"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"publisherPlace":"Amsterdam [u.a.] ; Dordrecht [u.a.] ; Oxford","dateIssuedDisp":"1990-","publisher":"Elsevier ; Kluwer ; Oxford Univ. Press","dateIssuedKey":"1990"}],"recId":"320428796","part":{"extent":"6","pages":"2576-2581","issue":"10","volume":"24","text":"24(2013), 10, Seite 2576-2581","year":"2013"},"language":["eng"],"title":[{"subtitle":"official journal of the European Society for Medical Oncology","title":"Annals of oncology","title_sort":"Annals of oncology"}],"pubHistory":["1.1990 -"]}],"physDesc":[{"extent":"6 S."}],"id":{"eki":["1480508411"],"doi":["10.1093/annonc/mdt270"]},"recId":"1480508411","origin":[{"dateIssuedDisp":"2013","dateIssuedKey":"2013"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"title":[{"title_sort":"Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP)","title":"Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP)"}]} | ||
| SRT | |a MULTICENTE2013 | ||